INTERNATIONAL PATENT: CXS THERAPEUTICS FILES APPLICATION FOR "FORMULATION OF GLIBENCLAMIDE AND LOW-DOSE METFORMIN FOR THE PREVENTION OR TREATMENT OF NEURODEGENERATIVE DISEASES"

GENEVA, March 17 -- CXS THERAPEUTICS (16 bis rue de la Republique37230 Fondettes) filed a patent application (PCT/EP2025/075349) for "FORMULATION OF GLIBENCLAMIDE AND LOW-DOSE METFORMIN FOR THE PREVENTION OR TREATMENT OF NEURODEGENERATIVE DISEASES" on Sep 05, 2025. With publication no. WO/2026/052795, the details related to the patent application was published on Mar 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BRACHET, Guillaume (16 bis rue de la Republique37230 Fondettes), MACKENZIE, Nadine (22 avenue de chavoye78124 Mareil sur Mauldre), ALIOUI, Anthony (132 avenue de la liberation6...